Literature DB >> 2039718

Acute infectious erythemas in children: a clinico-microbiological study.

H M Goodyear1, P W Laidler, E H Price, P A Kenny, J I Harper.   

Abstract

One-hundred children with an acute illness comprising fever and widespread erythematous rash were prospectively studied to determine whether clinical presentations are helpful in defining the causative agent and to identify the most appropriate microbiological specimens. An infectious agent was identified in 65 children; 72% were viruses, 20% were bacteria, 5% were Mycoplasma pneumoniae and in 3% both viruses and bacteria were detected. The most common infectious agents were picornaviruses, an atypical presentation of measles and Group A beta-haemolytic Streptococcus. Different patterns of rash occurred with each of these infections. The clinical presentation of a child with an acute febrile illness and rash was unhelpful in defining the causative agent. Routine management should include a throat swab for bacterial investigation and in selected cases a blood sample for IgM viral titres.

Entities:  

Mesh:

Year:  1991        PMID: 2039718     DOI: 10.1111/j.1365-2133.1991.tb00621.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

Review 1.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

2.  Analysis of Types of Skin Lesions and Diseases in Everyday Infectious Disease Practice-How Experienced Are We?

Authors:  Tomislava Skuhala; Vladimir Trkulja; Marin Rimac; Anja Dragobratović; Boško Desnica
Journal:  Life (Basel)       Date:  2022-06-29

3.  Reliability and accuracy of smartphones for paediatric infectious disease consultations for children with rash in the paediatric emergency department.

Authors:  İlker Devrim; Mine Düzgöl; Ahu Kara; İlknur Çağlar; Fatma Devrim; Nuri Bayram; Hurşit Apa
Journal:  BMC Pediatr       Date:  2019-01-31       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.